Clinical Trial Update: Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pantoprazole (Protonix) for maintenance of healing of esophagitis in pediatric participants aged 1-11 and 12-17 has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagitis

Drugs mentioned

• Protonix (pantoprazole)

Snippet

Sponsor: Pfizer | Conditions: Esophagitis | Phase 2 | Status: TERMINATED